Start-Up Stadium at BIO2023

Conferences
Written By Michael Abrahamson
Richard Austin stands on stage in front of blue background, presenting efficacy data at Start-Up Stadium event of BIO 2023 conference organized by AZ BIO.

Start-Up Stadium at #BIO2023 was a success! Dr. Richard Austin was able to present new preclinical efficacy data demonstrating Reglagene's medicine outperforming the standard of care treatment in a drug resistant glioblastoma line. Thank you to the attendees and judges!

Michael Abrahamson
Previous

New Research Opportunity for Students
Next

We’ve Redesigned Our Website